Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Posts

Una tecnología para ayudar a tratar el cáncer infantilgate2brain

A technology to help treat pediatric cancer

News
Una tecnología para ayudar a tratar el cáncer infantilExpansión. Madrid. La tecnología de…
May 4, 2022
https://gate2brain.com/wp-content/uploads/2022/05/Diseno-sin-titulo.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-05-04 08:13:032022-05-04 09:00:25A technology to help treat pediatric cancer

CATEGORIES

  • Events
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness SeriesApril 26, 2022 - 17:29
  • Gate2Brain is delighted to be attending next week's #AseBioInvestorDay2022, organised by Asociación Española de Bioempresas in Madrid.Gate2BrainGate2Brain attending Asebio Investor Day 2022April 21, 2022 - 14:46
  • 4YFN4YFNGATE2BRAIN will be participating in 4YFN at the Mobile World CongressFebruary 24, 2022 - 13:05
  • Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & InnovationFebruary 14, 2022 - 18:48
  • Innovatia 8.31st Innovatia 8.3 Investment ForumOctober 20, 2021 - 07:03

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • Catalonia participates in over 1,200 active clinical trials May 17, 2022 biocat
  • Startups from the BioRegion take part in TIRS Switzerland Edition to approach to Swiss ecosystem May 12, 2022 biocat
  • Barcelona to host BIOSPAIN 2023 May 12, 2022 biocat
  • HIGHLIGHTS: Improved working conditions for research staff, new investments by foreign companies and more sources of public funding April 28, 2022 biocat
  • Digitalizing clinical trials in Catalonia: lessons for the revolution April 25, 2022 biocat
  • Call now open for participants in “CRAASH Barcelona 2022” program April 19, 2022 biocat
  • HIGHLIGHTS: new rounds of investment, more funding in research, vaccines and innovation projects March 31, 2022 biocat
  • These are the seven startups taking part in the 30th Barcelona Healthcare Investment Forum March 28, 2022 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}